Trial Profile
A Long-term, Open-label Extension Study to Investigate the Long-term Safety of Alogliptin When Used in Combination With Sulfonylurea or Metformin in Subjects With Type 2 Diabetes in Japan
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Glimepiride; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 25 Mar 2011 New trial record